Recent Price Action
On 8/13/24, Catalyst Biosciences Inc (NASDAQ: CBIO) stock declined by -2.5%, closing at $10.40. However, trading volume in this decline was exceptionally low at 46% of normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 2.7% during the last week.
Current PriceTarget Research Rating
CBIO is expected to be a major Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Catalyst Biosciences is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment